<DOC>
	<DOCNO>NCT02543801</DOCNO>
	<brief_summary>This study evaluate two routinely use drug combination periarticular injection follow total hip arthroplasty pain control . One group receive liposomal bupivacaine , bupivacaine , clonidine , epinephrine ketorolac . The group receive ropivacaine , clonidine , epinephrine ketorolac .</brief_summary>
	<brief_title>A Clinical Trial Two Periarticular Multimodal Drug Injections Total Hip Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Hip Arthritis ( osteoarthritis , post traumatic , inflammatory , avascular necrosis ) Current use opioid drug Revision surgery Surgical complication ( femoral fracture implant insertion ) Inability provide Informed Consent</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>